HOWL
Werewolf Therapeutics, Inc. · Healthcare
Director Luke Evnin sold $185K of Werewolf Therapeutics, Inc.
Sold$185,221
$0.64Price
291,283Shares
−10%Stake
What HOWL did after the filing
- The stock from Tue, Dec 30 open, $0.63
- +4.6%
- S&P 500, same days
- −0.9%
Measured over 30 trading days, to the Feb 12 close.
Traded Mon, Dec 22. Filed Mon, Dec 29, 5:27 PM ET, after the close. Returns use the Dec 30 open and the Feb 12 close. Not investment advice.